Ventures Lundbeckfonden Ventures 5. februar 2016 Phase 2a Psoriasis Study Initiated with Ziarco’s Lead Compound ZPL-389 Lundbeckfonden Ventures 22. januar 2016 Spero Therapeutics Hires Former Biomedical Advanced Research and Development Authority (BARDA) Anti-Infectives Program Chief Lundbeckfonden Ventures 22. januar 2016 BONESUPPORTT ANNOUNCES APPOINTMENT OF LIFE SCIENCES INDUSTRY VETERAN, RICHARD DAVIES, AS NEW CHIEF EXECUTIVE OFFICER Lundbeckfonden Ventures 12. januar 2016 BONESUPPORTT ANNOUNCES 20,000 PATIENTS NOW TREATED WITH CERAMENT Lundbeckfonden Ventures 12. januar 2016 ICONIC THERAPEUTICS CLOSES SERIES C FINANCING WITH NEW AND EXISTING INVESTORS Lundbeckfonden Ventures 8. januar 2016 BONESUPPORTT ANNOUNCES CERAMENTT FOCUSED RESEARCH COLLABORATION WITH RIGSHOSPITALET, COPENHAGEN UNIVERSITY HOSPITAL Lundbeckfonden Ventures 8. januar 2016 Enterome announces collaboration with Johnson & Johnson Innovation focused on the discovery of novel targets and therapeutics for Crohn’s disease Lundbeckfonden Ventures 7. januar 2016 PSIOXUS THERAPEUTICS APPOINTS DR PAOLO PAOLETTI AS CHAIRMAN OF THE BOARD Lundbeckfonden Ventures 7. januar 2016 Takeda and Enterome Enter Strategic Drug Discovery Collaboration Focused on Microbiome Targets Across Multiple Gastrointestinal Disorders Lundbeckfonden Ventures 6. januar 2016 ACACIA PHARMA ANNOUNCES POSITIVE RESULTS FROM SECOND PIVOTAL PHASE 3 STUDY OF BAREMSIST (APD421) IN PREVENTION OF POST-OPERATIVE NAUSEA & VOMITING Sideinddeling Første side « Første Forrige side ‹‹ … Side 34 Side 35 Side 36 Side 37 Nuværende side 38 Side 39 Side 40 Side 41 Side 42 … Næste side ›› Sidste side Sidste »
